Colchicine 0.5 MG Oral Tablet Clinical Trials
2 recruitingDrug
Phase 32
Showing 1–2 of 2 trials
Recruiting
Phase 3
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Peripheral Arterial DiseaseInflammationAtherosclerosis of Extremities
Population Health Research Institute6,150 enrolled70 locationsNCT04774159
Recruiting
Phase 3
Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
Coronary Artery Disease
AZ Sint-Jan AV2,770 enrolled19 locationsNCT06095765